Genomic testing for patient care, clinical trials and translational research
The NGS lab at Washington University in St. Louis provides physicians with clinically validated next-generation sequencing for cancer, somatic overgrowth and a variety of constitutional diseases. Due to our extensive technological capabilities we also offer customized tests for clinical trials and clinical research.
Whether inherited or not, cancer is a genetic disease and decoding its DNA can help better diagnose, treat and manage it. Doctors can now take advantage of cutting-edge technologies, such as next-generation sequencing, to make personalized medicine a reality for many cancer patients.